Atomoxetine Tablets
Utilized to manage attention deficit hyperactivity disorder and formulated to support cognitive regulation.
Strengths: 10 · 18 · 25mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Strattera
- Therapeutic class
Selective Noradrenaline Reuptake Inhibitor (SNRI)
- Pharmacological class
Selective Noradrenaline Reuptake Inhibitor
- Minor side effects
nausea; vomiting; fatigue; decreased appetite
- Moderate side effects
abdominal pain; insomnia; dry mouth; irritability
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Eli Lilly
- Onset Time
2–4 weeks
- Duration
24 hours
- Storage instructions
Store below 25°C in a dry place, protected from light.
- Drug interactions
monoamine oxidase inhibitors; salbutamol; antihypertensives
- Age restrictions
Not recommended for children under six years of age.
Contraindications
hypersensitivity to atomoxetine; glaucoma; concurrent use of monoamine oxidase inhibitors; phaeochromocytoma
Precautions and warnings
monitor for emergent suicidal ideation; monitor heart rate and blood pressure; assess liver function if symptoms of jaundice occur
Serious side effects
suicidal ideation — requires immediate medical attention; hepatotoxicity — requires immediate medical attention; seizures — requires immediate medical attention; angioedema — requires immediate medical attention
Patient summary
Utilized to manage attention deficit hyperactivity disorder and formulated to support cognitive regulation.
Mechanism of action
Atomoxetine is a selective noradrenaline reuptake inhibitor. It works by increasing the levels of the neurotransmitter noradrenaline in the synaptic clefts, which helps improve attention, concentration, and impulse control in individuals with neurodevelopmental conditions.
Pregnancy and breastfeeding
Pregnancy: Use is not recommended unless clinically necessary. Breastfeeding: Caution is advised; consult a healthcare professional regarding potential risks.
Atomoxetine Tablets
Utilized to manage attention deficit hyperactivity disorder and formulated to support cognitive regulation.
Editorial Notes
- Active ingredient(s): Atomoxetine
- Listed indication(s): Attention Deficit Hyperactivity Disorder
Usually available as
- 180 tablets - 10 mg1255-10-mg-14956
- 60 tablets - 18 mg1255-18-mg-14970
- 60 tablets - 25 mg1255-25-mg-14959